NPT Co (TSE:311A) EBITDA Margin %: 0.00% (As of Apr. 2025)


TSE:311A NPT Co Ltd TSE:311A
9 GF Score
Price 円700.00
! 1 Warning Sign
View Full Analysis

What is NPT Co EBITDA Margin %?

NPT Co TSE:311A 9 EBITDA Margin % is 0.00% as of Apr. 2025. GuruFocus rates TSE:311A with a GF Score™ of 9/100. The stock has 1 warning sign investors should review. Among 952 Drug Manufacturers companies, NPT Co ranks worse than 105041.91% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. NPT Co's EBITDA for the six months ended in Apr. 2025 was 円-154.19 Mil. NPT Co's Revenue for the six months ended in Apr. 2025 was 円0.00 Mil. Therefore, NPT Co's EBITDA margin for the quarter that ended in Apr. 2025 was 0.00%.

NPT Co  (TSE:311A) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

NPT Co EBITDA Margin % Related Terms

NPT Co EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for NPT Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NPT Co EBITDA Margin % Chart

NPT Co Annual Data
Trend Oct22 Oct23 Oct24
EBITDA Margin %
0.00 0.00 0.00

NPT Co Semi-Annual Data
Oct22 Oct23 Apr24 Oct24 Apr25 Apr26
EBITDA Margin % Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

TSE:311A vs ZTS, UTHR: EBITDA Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, NPT Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NPT Co EBITDA Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, NPT Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where NPT Co's EBITDA Margin % falls into.


TSE:311A
9GF Score
NPT Co Ltd TSE:311A
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

NPT Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

NPT Co's EBITDA Margin % for the fiscal year that ended in Oct. 2024 is calculated as

EBITDA Margin %=EBITDA (A: Oct. 2024 )/Revenue (A: Oct. 2024 )
=-156.9/0
= %

NPT Co's EBITDA Margin % for the quarter that ended in Apr. 2025 is calculated as

EBITDA Margin %=EBITDA (Q: Apr. 2025 )/Revenue (Q: Apr. 2025 )
=-154.186/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 0.00% mean?
NPT Co (TSE:311A) has a EBITDA Margin % of 0.00% as of Apr. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on NPT Co and its competitors. According to the industry distribution chart, NPT Co ranks #999999 out of 952 companies in the Drug Manufacturers industry.
Is NPT Co's EBITDA Margin % too high?
NPT Co's current EBITDA Margin % is 0.00%. Based on the distribution chart, NPT Co ranks #999999 out of 952 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, NPT Co has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does NPT Co's EBITDA Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, NPT Co ranks #999999 out of 952 companies for EBITDA Margin %. This places NPT Co in the lower half of its industry. The industry median EBITDA Margin % is 12.47. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Drug Manufacturers company?
The median EBITDA Margin % among Drug Manufacturers companies is 12.47, based on 952 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on NPT Co and its competitors. For the Drug Manufacturers industry, the median EBITDA Margin % is 12.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NPT Co's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NPT Co stock overvalued right now?
NPT Co (TSE:311A) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. NPT Co's overall GF Score™ is 9/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For NPT Co (TSE:311A), the current EBITDA Margin % is 0.00% as of Apr. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

NPT Co Business Description

Address 3-5-7 Ariake, Room 9, 16th floor, TOC Ariake East Tower, Koto-ku, Tokyo, JPN, 135-0063
NPT Co Ltd is engaged in the Clinical development of new drugs and treatments for personalized medicine.
9GF Score

Get the complete analysis for TSE:311A

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円700.00
Price